{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:30:48Z","timestamp":1787099448821,"version":"build-2736575974"},"reference-count":92,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R011R01AI141549-01A1"],"award-info":[{"award-number":["R011R01AI141549-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL083808"],"award-info":[{"award-number":["T32HL083808"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000937","name":"M.J. Murdock Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006668","name":"Oregon Health and Science University","doi-asserted-by":"publisher","award":["1018784"],"award-info":[{"award-number":["1018784"]}],"id":[{"id":"10.13039\/100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006668","name":"Oregon Health and Science University","doi-asserted-by":"publisher","award":["R01AI145835"],"award-info":[{"award-number":["R01AI145835"]}],"id":[{"id":"10.13039\/100006668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.celrep.2022.111544","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T11:36:44Z","timestamp":1664969804000},"page":"111544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age"],"prefix":"10.1016","volume":"41","author":[{"given":"Timothy A.","family":"Bates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Schoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savannah K.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanhee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daehwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Messer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel E.","family":"Curlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikadu G.","family":"Tafesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4658-1261","authenticated-orcid":false,"given":"Lenette L.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2022.111544_bib1","article-title":"COVID-19 severity is associated with differential antibody Fc-mediated innate immune functions","volume":"12","author":"Adeniji","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2022.111544_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa2203965","article-title":"Effects of previous infection and vaccination on symptomatic Omicron infections","volume":"387","author":"Altarawneh","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.smim.2018.05.003","article-title":"Antibody glycosylation in inflammation, disease and vaccination","volume":"39","author":"Alter","year":"2018","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.celrep.2022.111544_bib4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-021-03681-2","article-title":"Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans","volume":"596","author":"Alter","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111544_bib5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMoa2115481","article-title":"Duration of protection against mild and severe disease by Covid-19 vaccines","volume":"386","author":"Andrews","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","article-title":"The impact of glycosylation on the biological function and structure of human immunoglobulins","volume":"25","author":"Arnold","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.celrep.2022.111544_bib7","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMoa2116414","article-title":"Homologous and heterologous Covid-19 booster vaccinations","volume":"386","author":"Atmar","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib8","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jaci.2020.04.059","article-title":"IgG Fc sialylation is regulated during the germinal center reaction following immunization with different adjuvants","volume":"146","author":"Bartsch","year":"2020","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.celrep.2022.111544_bib9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41591-021-01263-3","article-title":"Humoral signatures of protective and pathological SARS-CoV-2 infection in children","volume":"27","author":"Bartsch","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib10","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/jama.2021.11656","article-title":"Age-dependent neutralization of SARS-CoV-2 and P.1 variant by vaccine immune serum samples","volume":"326","author":"Bates","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.celrep.2022.111544_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25479-6","article-title":"Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum","volume":"12","author":"Bates","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111544_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108737","article-title":"Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2","volume":"34","author":"Bates","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.111544_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110368","article-title":"A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection","volume":"38","author":"Beaudoin-Bussi\u00e8res","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.111544_bib14","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1038\/s41591-021-01488-2","article-title":"Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial","volume":"27","author":"B\u00e9gin","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.15585\/mmwr.mm6912e2","article-title":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19) \u2014 United States, February 12\u2013March 16, 2020","volume":"69","author":"Boundy","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.celrep.2022.111544_bib16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1172\/JCI129520","article-title":"Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination","volume":"130","author":"Boudreau","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2022.111544_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41590-021-01088-9","article-title":"BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2","volume":"23","author":"Brewer","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2022.111544_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jim.2017.01.010","article-title":"Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles","volume":"443","author":"Brown","year":"2017","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.celrep.2022.111544_bib19","series-title":"COVID Data Tracker","article-title":"COVID-19 vaccinations in the United States","year":"2022"},{"key":"10.1016\/j.celrep.2022.111544_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41590-020-00828-7","article-title":"Proinflammatory IgG Fc structures in patients with severe COVID-19","volume":"22","author":"Chakraborty","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2022.111544_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm7853","article-title":"Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity","volume":"14","author":"Chakraborty","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib22","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cell.2015.10.027","article-title":"Dissecting polyclonal vaccine-induced humoral immunity against HIV using Systems serology","volume":"163","author":"Chung","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111544_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41541-018-0057-5","article-title":"The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial","volume":"3","author":"Coler","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.celrep.2022.111544_bib24","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMc2119270","article-title":"Effectiveness of BNT162b2 vaccine against Omicron variant in South Africa","volume":"386","author":"Collie","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-021-03739-1","article-title":"Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2","volume":"596","author":"Collier","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111544_bib26","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib27","article-title":"Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies","volume":"2","author":"Dufloo","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib28","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.chom.2022.04.014","article-title":"Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2","volume":"30","author":"Evans","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2022.111544_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110114","article-title":"Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern","volume":"37","author":"Farkash","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.111544_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2019.07.002","article-title":"A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation","volume":"473","author":"Fischinger","year":"2019","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.celrep.2022.111544_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.796481","article-title":"Sustained antibody-dependent NK cell functions in mild COVID-19 outpatients during convalescence","volume":"13","author":"Fuentes-Villalobos","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2022.111544_bib32","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cell.2020.12.015","article-title":"COVID-19-neutralizing antibodies predict disease severity and survival","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111544_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2021.12.033","article-title":"mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant","volume":"185","author":"Garcia-Beltran","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111544_bib34","article-title":"Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination","volume":"2","author":"Gorman","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/infdis\/jiz364","article-title":"Survivors of Ebola virus disease develop polyfunctional antibody responses","volume":"221","author":"Gunn","year":"2020","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2022.111544_bib36","doi-asserted-by":"crossref","first-page":"11931","DOI":"10.1073\/pnas.1609316113","article-title":"Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus","volume":"113","author":"He","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111544_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-27201-y","article-title":"Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response","volume":"12","author":"Herman","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111544_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf8654","article-title":"High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages","volume":"13","author":"Hoepel","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152042","article-title":"SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies","volume":"132","author":"Jeffery-Smith","year":"2022","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2022.111544_bib40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-022-04702-4","article-title":"FcgammaR-mediated SARS-CoV-2 infection of monocytes activates inflammation","volume":"606","author":"Junqueira","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111544_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm2311","article-title":"mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions","volume":"14","author":"Kaplonek","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006862","article-title":"Viridot: an automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus","volume":"12","author":"Katzelnick","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.celrep.2022.111544_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00561-21","article-title":"Age-dependent reduction in neutralization against Alpha and Beta variants of BNT162b2 SARS-CoV-2 vaccine-induced immunity","volume":"9","author":"Kawasuji","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.celrep.2022.111544_bib44","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","article-title":"T cell responses to SARS-CoV-2 spike cross-recognize Omicron","volume":"603","author":"Keeton","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111544_bib45","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.759688","article-title":"Detection of antibody responses against SARS-CoV-2 in plasma and saliva from vaccinated and infected individuals","volume":"12","author":"Klingler","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2022.111544_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-30681-1","article-title":"Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine","volume":"13","author":"Kurhade","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111544_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8378","article-title":"Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity","volume":"371","author":"Larsen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111544_bib49","article-title":"Decay of Fc-dependent antibody functions after mild to moderate COVID-19","volume":"2","author":"Lee","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-021-03693-y","article-title":"BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants","volume":"596","author":"Liu","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111544_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat7796","article-title":"Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement","volume":"3","author":"Lofano","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2022.111544_bib52","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111544_bib53","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri.2017.106","article-title":"Beyond binding: antibody effector functions in infectious diseases","volume":"18","author":"Lu","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2022.111544_bib54","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41591-021-01355-0","article-title":"Delayed production of neutralizing antibodies correlates with fatal COVID-19","volume":"27","author":"Lucas","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib55","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S2213-2600(21)00220-4","article-title":"BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers","volume":"9","author":"Lustig","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib56","article-title":"Antigen-specific antibody glycosylation is regulated via vaccination","volume":"12","author":"Mahan","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2022.111544_bib57","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jim.2014.12.004","article-title":"A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis","volume":"417","author":"Mahan","year":"2015","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.celrep.2022.111544_bib58","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion","volume":"599","author":"Mlcochova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111544_bib59","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41564-021-01053-0","article-title":"Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario","volume":"7","author":"Nasreen","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2022.111544_bib60","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1126\/science.1118948","article-title":"Divergent immunoglobulin g subclass activity through selective Fc receptor binding","volume":"310","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111544_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2277","article-title":"Potency of BNT162b2 and mRNA-1273 vaccine-induced neutralizing antibodies against severe acute respiratory syndrome-CoV-2 variants of concern: a systematic review of in\u00a0vitro studies","volume":"32","author":"Noori","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.celrep.2022.111544_bib62","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jaci.2012.02.037","article-title":"Tolerance induction with T\u00a0cell-dependent protein antigens induces regulatory sialylated IgGs","volume":"129","author":"Oefner","year":"2012","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.celrep.2022.111544_bib63","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fimmu.2017.00646","article-title":"Fc-galactosylation of human immunoglobulin gamma isotypes improves C1q binding and enhances complement-dependent cytotoxicity","volume":"8","author":"Peschke","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2022.111544_bib64","first-page":"372","article-title":"Composition of the immunoglobulin G glycome associates with the severity of COVID-19","volume":"31","author":"Petrovi\u0107","year":"2021","journal-title":"Glycobiology"},{"key":"10.1016\/j.celrep.2022.111544_bib65","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ni.2939","article-title":"Type I and type II Fc receptors regulate innate and adaptive immunity","volume":"15","author":"Pincetic","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2022.111544_bib66","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","article-title":"Considerable escape of SARS-CoV-2 Omicron to antibody neutralization","volume":"602","author":"Planas","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111544_bib67","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1172\/JCI82695","article-title":"Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity","volume":"125","author":"Quast","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2022.111544_bib68","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(21)00897-7","article-title":"Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2022.111544_bib69","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJMc2202542","article-title":"Efficacy of a fourth dose of Covid-19 mRNA vaccine against Omicron","volume":"386","author":"Regev-Yochay","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib70","article-title":"SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity","volume":"3","author":"Richardson","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009551","article-title":"Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: a systematic review and meta-analysis","volume":"15","author":"Savage","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.celrep.2022.111544_bib72","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201993","article-title":"Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in\u00a0vivo","volume":"218","author":"Sch\u00e4fer","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib73","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41577-020-0348-8","article-title":"Considering how biological sex impacts immune responses and COVID-19 outcomes","volume":"20","author":"Scully","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2022.111544_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22236-7","article-title":"Systems serology detects functionally distinct coronavirus antibody features in children and elderly","volume":"12","author":"Selva","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111544_bib75","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/acs.biochem.8b01048","article-title":"Recognition of human IgG1 by Fcgamma receptors: structural insights from hydrogen-deuterium Exchange and fast photochemical oxidation of proteins coupled with mass spectrometry","volume":"58","author":"Shi","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.celrep.2022.111544_bib76","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.cell.2021.03.029","article-title":"Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein","volume":"184","author":"Suryadevara","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111544_bib77","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.abl6184","article-title":"Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles","volume":"374","author":"Syed","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111544_bib78","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/s41591-021-01583-4","article-title":"BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar","volume":"27","author":"Tang","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111544_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247640","article-title":"Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma","volume":"16","author":"Tso","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2022.111544_bib80","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.immuni.2021.08.015","article-title":"Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy","volume":"54","author":"Ullah","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2022.111544_bib81","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4049\/jimmunol.1502136","article-title":"The emerging importance of IgG Fab glycosylation in immunity","volume":"196","author":"van de Bovenkamp","year":"2016","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111544_bib82","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.4049\/jimmunol.2100399","article-title":"Fc galactosylation promotes hexamerization of human IgG1, leading to enhanced classical complement activation","volume":"207","author":"van Osch","year":"2021","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2022.111544_bib83","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1021\/ac501573g","article-title":"Rapid magnetic bead based sample preparation for automated and high throughput N-glycan analysis of therapeutic antibodies","volume":"86","author":"V\u00e1radi","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.celrep.2022.111544_bib84","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eji.202149491","article-title":"Altered IgG glycosylation at COVID-19 diagnosis predicts disease severity","volume":"52","author":"Vicente","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2022.111544_bib85","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03275-y","article-title":"BNT162b vaccines protect rhesus macaques from SARS-CoV-2","volume":"592","author":"Vogel","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111544_bib86","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111544_bib87","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-022-05053-w","article-title":"Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5","volume":"608","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111544_bib88","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.61312","article-title":"Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants","volume":"9","author":"Weisblum","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2022.111544_bib89","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.cell.2021.02.026","article-title":"Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection","volume":"184","author":"Winkler","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111544_bib90","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.2021.18178","article-title":"Effect of convalescent plasma on organ support-free days in critically Ill patients with COVID-19: a randomized clinical trial","volume":"326","author":"Abdelhady","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.celrep.2022.111544_bib91","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2022.2038531","article-title":"The Fab portion of immunoglobulin G has sites in the CL domain that interact with Fc gamma receptor IIIa","volume":"14","author":"Yamaguchi","year":"2022","journal-title":"mAbs"},{"key":"10.1016\/j.celrep.2022.111544_bib92","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-021-04017-w","article-title":"Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy","volume":"599","author":"Yamin","year":"2021","journal-title":"Nature"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722014000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722014000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:49:26Z","timestamp":1761911366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124722014000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2211124722014000"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2022.111544","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.08.12.22278726","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2022.111544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"111544"}}